SKIN - The Beauty Health Company
SkinStylus SteriLock MicroSystem Now the Only Microneedling Device with Indications for Facial Acne Scars, Periorbital Wrinkles, and Abdominal Scars
An advanced, non-invasive scalp treatment with no downtime, featuring newly engineered tips and clinically proven to visibly improve scalp health and the appearance of fuller, thicker-looking hair An advanced, non-invasive scalp treatment with no downtime, featuring newly engineered tips and clinically proven to visibly improve scalp health and the appearance of fuller, thicker-looking hair
Explore how SkinHealth Systems Inc.'s (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Beauty Health NASDAQ: SKIN, referred to by executives as SkinHealth Systems following a recent rebrand, reported first-quarter 2026 net sales of $64.9 million, down 6.7% from the prior year, as weaker device placements continued to weigh on growth. The company said adjusted EBITDA rose 17% year over year to $8.5 million, exceeding the high end of its guidance range.
SkinHealth Systems Inc. (SKIN) Q1 2026 Earnings Call Transcript
SkinHealth Systems Inc. (SKIN) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.08 per share a year ago.
The headline numbers for SkinHealth Systems Inc. (SKIN) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 (“Q1 2026”).
SkinHealth Systems Inc. (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients' healing time following procedures. At the heart of the brand is its innovative NAC Y2™, a pioneering complex designed to sup.
LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026.
LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced the appointment of three new independent directors to its Board of Directors (the “Board”): Mr.
LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) today announced a corporate rebrand to SkinHealth Systems Inc., marking its evolution into a clinically driven, science-backed medical aesthetics company.
Evaluate Beauty Health's (SKIN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Shares of The Beauty Health Company (NASDAQ: SKIN - Get Free Report) have been given an average recommendation of "Reduce" by the eight analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and one has issued a buy recommendation on
The Beauty Health Company (SKIN) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for Beauty Health (SKIN) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.08 per share a year ago.
LONG BEACH, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2025 (“Q4 2025”).
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Beauty Health (SKIN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.